Multiparametric risk stratification in patients with mild to moderate chronic heart failure

Angela Beatrice Scardovi1, Renata De Maria, Claudio Coletta

  • 1Department of Cardiology, S. Spirito Hospital, Rome, Italy.

Insights

Combining cardiopulmonary exercise tests and echocardiography offers superior risk prediction in heart failure patients compared to brain natriuretic peptide alone. These multiparametric approaches improve prognostic stratification for better patient management.

Area of Science:

  • Cardiology
  • Pulmonology
  • Geriatrics

Background:

  • Prognostic stratification in mild-to-moderate systolic heart failure (HF) remains challenging.
  • The combined utility of brain natriuretic peptide (BNP), cardiopulmonary exercise testing (CPx), and echocardiography is not fully understood.

Purpose of the Study:

  • To evaluate the prognostic value of BNP, CPx-derived parameters, and echocardiographic findings in predicting outcomes in patients with mild-to-moderate systolic HF.
  • To determine if a multiparametric approach improves risk stratification compared to individual markers.

Main Methods:

  • A cohort of 244 stable outpatients with NYHA Class I-III HF and LVEF < 45% underwent BNP measurement, Doppler echocardiography, and maximal CPx.
  • Follow-up for 18 months assessed all-cause mortality or HF re-hospitalization.
  • Statistical analysis included Cox proportional hazards models to identify independent predictors.

Main Results:

  • BNP levels, NYHA Class III, creatinine clearance, and hemoglobin predicted outcomes.
  • Restrictive filling pattern (RFP) on echocardiography (HR 3.36) and enhanced ventilatory response to exercise (EVR, HR 1.50) outperformed BNP (HR 1.35) as prognostic markers.
  • Patients with both RFP and EVR had a significantly higher risk (HR 7.30) of death or HF admission.

Conclusions:

  • A multiparametric approach integrating echocardiography and CPx is crucial for optimal risk stratification in elderly patients with mild-to-moderate HF.
  • High-risk patients identified by these methods require closer monitoring and tailored therapeutic strategies, including non-pharmacologic options.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...